Lung cancer with limited spread, treated with a combination of therapies

What happened, in summary

A woman in her early 40s developed unusual, prolonged headaches with pain at the back of her head and neck, together with nausea. Investigation found a single brain metastasis and a small primary lung adenocarcinoma. No other distant disease was detected, and the lymph nodes were not involved. The cancer was classified as Stage IVA oligometastatic disease, pT1N0M1b.

The brain lesion was removed surgically. She then underwent right upper lobectomy with systematic mediastinal lymph-node dissection. The lung tumor was removed with clear margins and had not invaded the pleura. All 17 sampled lymph nodes were negative.

One week after the lung operation, she began whole-brain radiation, receiving 30 Gy in 10 treatments. This was followed by 6 cycles of carboplatin and gemcitabine. The treatment plan combined local treatment of both known cancer sites with systemic chemotherapy.

After therapy, she entered long-term surveillance with regular chest and brain imaging and other follow-up tests. She remained asymptomatic and did not develop a new neurological problem. At 164 months—more than 13 years—there was still no evidence of recurrence. She reported excellent quality of life and no lasting neurological effect from the brain metastasis or its treatment. Her course represents unusually durable control after intensive treatment of a solitary brain metastasis and an early lung primary.

Because only 1 distant site was present, the team treated both the brain metastasis and lung primary with curative intent. Long-term surveillance confirmed durable disease control.